On July 23, 2025, Natco Pharma Ltd announced its board approved the acquisition of 51,643,319 shares of Adcock Ingram Holdings for ZAR 75.00 (approx. US$ 4.27) per share, totaling about ZAR 2,000 crores, and plans to establish a wholly owned subsidiary in South Africa with an investment of up to Rs. 2,100 crores.